繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

BiomX GAAP每股收益为-0.19美元

2025-08-13 19:28

  • BiomX press release (NYSE:PHGE): Q2 GAAP EPS of -$0.19.
  • Cash balance and restricted cash as of June 30, 2025, were $15.2 million, compared to $18 million as of December 31, 2024.
  • The decrease was primarily due to net cash used in operating activities.
  • BiomX estimates its cash, cash equivalents and restricted cash are sufficient to fund its operations into the first quarter of 2026.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。